Phase 3 trial of eribulin versus dacarbazine for the treatment of advanced liposarcoma or leiomyosarcoma | Prof Patrick Schöffski at Annual Meeting 2015 - 101271

Spotlight
Video

Phase 3 trial of eribulin versus dacarbazine for the treatment of advanced liposarcoma or leiomyosarcoma | Prof Patrick Schöffski at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Patrick Schöffski, MD, of University Hospitals Leuven, Leuven, Belgium, discusses the results of a randomised, open-label, multicentre, phase 3 trial of the microtubule dynamics inhibitor, eribulin, versus dacarbazine for the treatment of patients with advanced liposarcoma or leiomyosarcoma.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 07/02/15
Added : 3 years ago
Category : Soft Tissue Sarcoma



Recommended

Nothing found.

More From EMJ

Nothing found.